Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors
Posted innews Ophthalmology Pediatrics

Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors

This study compares retreatment rates and timing in retinopathy of prematurity among infants treated with intravitreal bevacizumab versus laser therapy, highlighting lower early retreatment rates and delayed intervention in the bevacizumab group, especially in high-risk premature infants.
Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology
Posted innews Ophthalmology Pediatrics

Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology

This review synthesizes current evidence on neurodevelopmental outcomes after treating retinopathy of prematurity with anti-VEGF injections versus laser photocoagulation, finding no significant differences in long-term cognitive or developmental effects.